Skip to main content

Table 2 Logistic regression analysis for the proposed predictors of liver decompensation

From: Role of residual liver volumetry and function in prediction of liver tolerability after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients: deriving a clinical decision support score

Predictor Univariate analysis
B SE Wald Sig. OR (95% CI)
Demographic criteria
 • Age (years) 0.054 0.020 7.217 0.007 1.055 (1.015–1.097)
 • Sex (male) − 0.001 0.284 0.000 0.996 0.999 (0.573–1.741)
Pre-intervention reserve liver functions
 • ALT (IU/L) 0.027 0.015 3.540 0.060 1.028 (0.999–1.057)
 • AST (IU/L) 0.025 0.013 3.573 0.059 1.025 (0.999–1.052)
 • s.albumin (gm/dl) − 6.388 0.909 49.331 0.000 0.002 (0.000–0.010)
 • s.bilirubin (mg/dl) 3.122 0.694 20.254 0.000 22.692 (5.826–88.381)
 • PC (%) − 0.178 0.036 23.891 0.000 0.837 (0.779–0.899)
Pre-interventional liver volumetric measures
 • Liver volume (LV) (cm3) 0.000 0.000 1.565 0.211 1.000 (1.000–1.001)
 • Tumor volume (TV) (cm3) 0.002 0.000 26.546 0.000 1.002 (1.001–1.0023)
 • Residual volume (RV) (cm3) − 0.001 0.000 9.287 0.002 0.999 (0.998–0.999)
 • Residual to liver volumetric ratio (RLVR) − 8.514 1.402 36.861 0.000 0.000 (0.000–0.003)
Other evaluated clinical and laboratory parameters
 • Spleen diameter (cm) 0.106 0.058 3.314 0.069 1.111 (0.992–1.245)
 • s.creatinine (mg/dl) − 0.953 1.008 0.894 0.345 0.386 (0.054–2.780)
 • Platelets (× 103/mm3) − 0.006 0.004 2.384 0.123 0.994 (90.987–1.002)
 • AFP (ng/ml) 0.001 0.001 3.592 0.058 1.001 (1.000–1.002)
 • Child-Pugh score 1.536 0.232 43.663 0.000 4.646 (2.946–7.358)